Marla Hochfeld

4.7k total citations · 1 hit paper
8 papers, 532 citations indexed

About

Marla Hochfeld is a scholar working on Psychiatry and Mental health, Rheumatology and Infectious Diseases. According to data from OpenAlex, Marla Hochfeld has authored 8 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 2 papers in Rheumatology and 1 paper in Infectious Diseases. Recurrent topics in Marla Hochfeld's work include Schizophrenia research and treatment (4 papers), Bipolar Disorder and Treatment (2 papers) and Obsessive-Compulsive Spectrum Disorders (1 paper). Marla Hochfeld is often cited by papers focused on Schizophrenia research and treatment (4 papers), Bipolar Disorder and Treatment (2 papers) and Obsessive-Compulsive Spectrum Disorders (1 paper). Marla Hochfeld collaborates with scholars based in United States, United Kingdom and Switzerland. Marla Hochfeld's co-authors include Xiangyi Meng, Leslie Citrome, Éric Lespessailles, Stephen Hall, Philip J. Mease, Georg Schett, Arthur Kavanaugh, Douglas R. Hough, Juan J. Gómez‐Reino and ChiaChi Hu and has published in prestigious journals such as Annals of the Rheumatic Diseases, Schizophrenia Research and Journal of Clinical Psychopharmacology.

In The Last Decade

Marla Hochfeld

8 papers receiving 513 citations

Hit Papers

Treatment of psoriatic arthritis in a phase 3 randomised,... 2014 2026 2018 2022 2014 100 200 300

Peers

Marla Hochfeld
Adeel Nasir United States
C. M. Tench United Kingdom
Ann Brownfield United Kingdom
Tanja Falter Germany
A Unger United Kingdom
L. D. Jacobs Netherlands
Nicole M. Orzechowski United States
Adeel Nasir United States
Marla Hochfeld
Citations per year, relative to Marla Hochfeld Marla Hochfeld (= 1×) peers Adeel Nasir

Countries citing papers authored by Marla Hochfeld

Since Specialization
Citations

This map shows the geographic impact of Marla Hochfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marla Hochfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marla Hochfeld more than expected).

Fields of papers citing papers by Marla Hochfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marla Hochfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marla Hochfeld. The network helps show where Marla Hochfeld may publish in the future.

Co-authorship network of co-authors of Marla Hochfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Marla Hochfeld. A scholar is included among the top collaborators of Marla Hochfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marla Hochfeld. Marla Hochfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Weiden, Peter J., Leslie Citrome, Gus Alva, et al.. (2014). A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia. Schizophrenia Research. 153(1-3). 160–168. 16 indexed citations
2.
Kavanaugh, Arthur, Philip J. Mease, Juan J. Gómez‐Reino, et al.. (2014). Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor. Annals of the Rheumatic Diseases. 73(6). 1020–1026. 341 indexed citations breakdown →
3.
Hochfeld, Marla, et al.. (2012). Changes in weight and metabolic parameters following long-term iloperidone use: A meta-analysis of data from 9 Phase II and III trials of iloperidone. Open Journal of Psychiatry. 2(4). 414–422. 1 indexed citations
4.
Potkin, Steven G., Sheldon Preskorn, Marla Hochfeld, & Xiangyi Meng. (2012). A Thorough QTc Study of 3 Doses of Iloperidone Including Metabolic Inhibition Via CYP2D6 and/or CYP3A4 and a Comparison to Quetiapine and Ziprasidone. Journal of Clinical Psychopharmacology. 33(1). 3–10. 57 indexed citations
5.
Targum, Steven D., et al.. (2012). A global measure to assess switching antipsychotic medications in the treatment of schizophrenia. Human Psychopharmacology Clinical and Experimental. 27(5). 455–463. 5 indexed citations
6.
Citrome, Leslie, Xiangyi Meng, & Marla Hochfeld. (2011). Efficacy of iloperidone in schizophrenia: A PANSS five-factor analysis. Schizophrenia Research. 131(1-3). 75–81. 71 indexed citations
7.
Citrome, Leslie, Xiangyi Meng, Marla Hochfeld, & Stephen M. Stahl. (2011). Efficacy of iloperidone in the short‐term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo‐ and active‐controlled trials. Human Psychopharmacology Clinical and Experimental. 27(1). 24–32. 12 indexed citations
8.
Hochfeld, Marla, et al.. (1994). Pregnancy complicated by primary antiphospholipid antibody syndrome.. PubMed. 83(5 Pt 2). 804–5. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026